Article
MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1
18 Oct 2023
Abstract excerpt
Mesenchymal stem cell (MSC)-based therapy has emerged as a promising treatment for spinal cord injury (SCI), but improving the neurogenic potential of MSCs remains a challenge. Mixed lineage leukemia 1 (MLL1), an H3K4me3 methyltransferases, plays a critical role in regulating lineage-specific gene expression and influences neurogenesis. In this study, we investigated the role and mechanism of MLL1 in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
